Incretin-based therapies have transformed modern metabolic medicine. While GLP-1 therapies have gained global recognition for weight management and metabolic improvement, newer dual incretin therapies combining GLP-1 and GIP are now emerging as advanced options.
At Medical Wellness by Hertitude, incretin therapies are evaluated as part of personalized metabolic programs rather than used as isolated weight-loss solutions.
What Are Incretin Hormones?
Incretins are hormones released by the gut in response to food intake. They help regulate:
- Insulin secretion
- Blood sugar balance
- Appetite control
- Energy metabolism
The two primary incretin hormones involved in modern therapy include:
- GLP-1 (Glucagon-Like Peptide-1)
- GIP (Glucose-Dependent Insulinotropic Polypeptide)
How GLP-1 Therapy Works
GLP-1 therapies mimic natural hormone activity to:
- Slow gastric emptying
- Increase satiety
- Improve insulin sensitivity
- Reduce appetite dysregulation
These therapies have become widely used for metabolic syndrome and weight management.
What Makes GLP-1/GIP Dual Therapy Different?
Dual incretin therapy targets two metabolic pathways simultaneously.
Potential benefits may include:
- Enhanced metabolic signaling
- Improved insulin response
- More effective appetite regulation
- Improved fat metabolism support
Research continues to explore long-term metabolic and cardiovascular outcomes.
Why Dual Incretin Therapy Requires Medical Supervision
Despite their effectiveness, incretin therapies are not appropriate for all individuals. Medical evaluation is essential to assess:
- Nutritional status
- Hormonal balance
- Muscle preservation
- Gastrointestinal tolerance
- Long-term metabolic sustainability
At Hertitude, incretin therapies are integrated into medically supervised metabolic programs.
Who May Benefit From Dual Incretin Therapy?
This therapy may be considered for individuals experiencing:
- Metabolic resistance
- Insulin dysregulation
- Weight plateau despite lifestyle modification
- Elevated cardiometabolic risk
